Vallee et al. [24] also pointed out that TTF-1 was positive in almost all EGFR-mutated patients (98.0%), and the sensitivity and specificity of TTF-1 in detecting EGFR mutation in lung adenocarcinoma were 99.1% and 36.4%, respectively [47]. This evidence concerns the gene EGFR and lung adenocarcinoma.